Does UnitedHealthcare Cover Vyvanse?
The verdict
Covered on most plans
UnitedHealthcare covers Vyvanse through OptumRx — generic lisdexamfetamine is now formulary-preferred on the OptumRx standard formulary, brand Vyvanse is non-preferred as generic supply stabilizes. A Schedule II 70 mg/day quantity limit and ADHD diagnosis requirement apply across all lines of business. UHC is one of the broadest multi-LOB carriers (commercial, ACA, Medicare Advantage/Part D, and Medicaid), and OptumRx applies consistent generic-first logic across all of them.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.
Key facts
UnitedHealthcare manages pharmacy benefits through OptumRx, covering commercial, Medicare Advantage, ACA, and Medicaid lines of business.
UnitedHealthcare / OptumRx plan documentation
The DEA set the 2026 lisdexamfetamine APQ at 51,290,743 grams (effective January 5, 2026) — a major quota increase to address ongoing supply shortfalls.
DEA Final Order, effective January 5, 2026
Generic lisdexamfetamine costs ~$200–$360/month cash (or ~$60–$70 with coupon) versus ~$400–$558 for brand Vyvanse.
GoodRx cash price data; Takeda patient assistance
Medicare vs. commercial coverage
Whether UnitedHealthcare covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Under Medicare Part D and Medicare Advantage/Part D (UHC's large Medicare book), generic lisdexamfetamine is covered and preferred; brand Vyvanse may require prior authorization as generic supply improves. A Schedule II 70 mg/day quantity limit applies. Medicare beneficiaries cannot use manufacturer savings cards — the generic is the financially important path. Verify on the OptumRx Part D formulary for your specific UHC plan.
Commercial / Employer
Group & marketplace plans
On Commercial/Employer plans (OptumRx standard formulary), generic lisdexamfetamine is preferred at a low tier; brand Vyvanse is non-preferred. On ACA/Individual plans, the same OptumRx generic-preferred pattern applies with 70 mg/day QL. On UHC Community Plan Medicaid managed care, generic lisdexamfetamine is covered per state PDL with PA and QL requirements. OptumRx allows pharmacist override and shortage-documented PA for brand Vyvanse when the generic is temporarily unavailable. Verify tiers on the OptumRx formulary for your specific plan.
The 5 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Generic lisdexamfetamine: ~$200–$360 per month cash (as low as ~$60–$70 with coupon). Brand Vyvanse: ~$400–$558 per month. Estimates only — varies by pharmacy and dose.
List price with no coverage — before any manufacturer savings card.
With coverage
Generic: preferred-tier copay via OptumRx (lowest out-of-pocket; plan-specific — verify on OptumRx formulary). Brand Vyvanse: higher non-preferred tier copay. UHC Community Plan Medicaid: nominal ($0–$4 typical). Exact cost-share depends on specific plan design.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates and vary by plan tier, pharmacy, and dose. Confirm with your UHC plan or the OptumRx formulary. Medicare members cannot use manufacturer savings cards; Medicaid members pay nominal cost-share.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search the OptumRx formulary for your UHC plan
Log in to the UnitedHealthcare member portal at myuhc.com or the OptumRx member portal and search for 'lisdexamfetamine' or 'Vyvanse.' The tool shows your plan's tier, 70 mg/day quantity limit, and any PA requirement. The formulary is your authoritative source — UHC has many plan types and tiers vary.
- 2
Call UHC Member Services
Call the number on the back of your UHC card to confirm Vyvanse coverage on your specific plan — including whether generic or brand applies, your copay estimate, whether PA is required, and how to initiate the OptumRx PA process.
- 3
Have your prescriber submit PA and check pharmacy stock
If prior authorization is required, your prescriber submits clinical documentation through the OptumRx PA portal including your ADHD or BED diagnosis. Also ask your pharmacy about current generic lisdexamfetamine stock — if unavailable, your prescriber can document the shortage for OptumRx to approve brand Vyvanse. Stock has varied week to week since the shortage began.
Options if UnitedHealthcare won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The OptumRx-preferred option. FDA-approved August 2023; ~$60–$70/month with coupon vs. $400–$558 for brand Vyvanse. Therapeutically equivalent to brand.
Generic amphetamine/dextroamphetamine (Adderall generic)
OptumRx-preferred for ADHD with a separate ~60 mg/day QL. May be available when lisdexamfetamine supply is constrained — check with your pharmacy.
Generic methylphenidate (Ritalin)
Non-amphetamine Schedule II stimulant. Generally preferred low-tier on OptumRx and may be useful when amphetamine-class supply is limited.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
UnitedHealthcare covers both through OptumRx, but generic lisdexamfetamine is now the formulary-preferred option and brand Vyvanse is non-preferred. In 2024, OptumRx and UHC temporarily added brand Vyvanse back to preferred status when generic supply was thin — as the DEA increased production quotas (2026 lisdexamfetamine APQ: 51.3 million grams) and generic supply improved, those add-backs are being reversed. For brand Vyvanse, a formulary exception is typically required. Check your current OptumRx plan formulary — coverage status can change mid-year.
UnitedHealthcare applies a 70 mg/day quantity limit for lisdexamfetamine through OptumRx, consistent with the FEP standard for this drug class. Prescriptions above 70 mg/day trigger additional clinical review and PA. Your prescriber should be aware of this cap before submitting a prescription. Age-based PA edits also apply — adults 22 and older typically require PA for ADHD diagnosis confirmation. Verify on the OptumRx formulary or call UHC member services to confirm your plan's exact rules.
All three reach the same generic-lisdexamfetamine-preferred outcome, but the PBMs differ: UHC uses OptumRx, Aetna uses CVS Caremark (with the best-documented 70 mg/day and age-22 PA anchor via Policy 5.60.024), and Cigna uses Express Scripts. The formulary documents, PA portals, and step-therapy rules are PBM-specific. Aetna's CVS Caremark FEP criteria provide the most publicly documented numbers; UHC's OptumRx and Cigna's Express Scripts follow the same generic-preferred logic, verified on their respective formularies.
Vyvanse is FDA-approved for moderate-to-severe binge-eating disorder in adults — the only Schedule II stimulant with this indication. Coverage for the BED indication through UHC depends on your specific OptumRx plan formulary and PA criteria. Some UHC commercial plans cover Vyvanse for BED with a documented diagnosis; others limit coverage to ADHD. Check your OptumRx plan formulary or call UHC member services at the number on your card to confirm whether BED is a covered indication on your specific plan.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.